|
|
||||||||
-induced endothelium-independent vasodilation: a role
for phospholipase A2-dependent
ceramide signaling
Department of Physiology, University of Michigan, Ann Arbor, Michigan 48109
Ceramide is a novel second messenger generated
by hydrolysis of membrane sphingomyelin by a neutral sphingomyelinase
(nSMase). Cytokines such as tumor necrosis factor-
(TNF-
) have
been shown to increase intracellular ceramide through phospholipase
A2
(PLA2)-dependent activation of
nSMase. TNF-
has been shown to cause endothelium-independent relaxation in isolated blood vessels. We have previously shown that
exogenously applied sphingomyelinase and ceramide cause
endothelium-independent vasodilation in rat thoracic aortas (D. G. Johns, H. Osborn, and R. C. Webb. Biochem. Biophys.
Res. Commun. 237: 95-97, 1997). In the present
study, we tested the hypothesis that ceramide mediates TNF-
-induced
vasodilation. In phenylephrine-contracted rat thoracic aortic rings (no
endothelium), TNF-
caused concentration-dependent relaxation in the
presence of cyclooxygenase and lipoxygenase inhibitors. The
phospholipase A2 antagonist
7,7-dimethyl-(5Z,8Z)-eicosadienoic acid (DEDA; 50 µM) and the nonselective
PLA2 antagonist quinacrine (30 µM) inhibited TNF-
-induced relaxation. In cultured rat aortic vascular smooth muscle cells, TNF-
(10
7 g/ml) increased
intracellular ceramide 1.5-fold over basal level (0.08 nmol/mg
protein), which was blocked by the
PLA2 antagonist DEDA (50 µM). We
conclude that PLA2 activation and
increased ceramide generation play a role in mediating TNF-
-induced
endothelium-independent vasodilation.
cytokines; smooth muscle relaxation; sphingolipid signaling; sepsis
This article has been cited by other articles:
![]() |
H. I. Abdullah, P. L. Pedraza, S. Hao, K. D. Rodland, J. C. McGiff, and N. R. Ferreri NFAT regulates calcium-sensing receptor-mediated TNF production Am J Physiol Renal Physiol, May 1, 2006; 290(5): F1110 - F1117. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Y. Cheranov and J. H. Jaggar TNF-{alpha} dilates cerebral arteries via NAD(P)H oxidase-dependent Ca2+ spark activation Am J Physiol Cell Physiol, April 1, 2006; 290(4): C964 - C971. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Gulbins and P. L. Li Physiological and pathophysiological aspects of ceramide Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2006; 290(1): R11 - R26. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Tsai, M. Wang, M. Clauss, P. Sun, and D. R. Meldrum Endothelial monocyte-activating polypeptide II causes NOS-dependent pulmonary artery vasodilation: a novel effect for a proinflammatory cytokine Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2004; 287(4): R767 - R771. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. D. Constable, G. W. Smith, G. E. Rottinghaus, M. E. Tumbleson, and W. M. Haschek Fumonisin-induced blockade of ceramide synthase in sphingolipid biosynthetic pathway alters aortic input impedance spectrum of pigs Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2034 - H2044. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Levade, N. Auge, R. J. Veldman, O. Cuvillier, A. Negre-Salvayre, and R. Salvayre Sphingolipid Mediators in Cardiovascular Cell Biology and Pathology Circ. Res., November 23, 2001; 89(11): 957 - 968. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Awasthi, J. Vivekananda, V. Awasthi, D. Smith, and R. J. King CTP:phosphocholine cytidylyltransferase inhibition by ceramide via PKC-{alpha}, p38 MAPK, cPLA2, and 5-lipoxygenase Am J Physiol Lung Cell Mol Physiol, July 1, 2001; 281(1): L108 - L118. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Kleine, G. Liu, N. Leblanc, and R. L. Hebert Bradykinin stimulates ceramide production by activating specific BK-B1 receptor in rat small artery Am J Physiol Heart Circ Physiol, January 1, 2002; 282(1): H175 - H183. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |